stockrowCollegium Pharmaceutical, Inc. (COLL) vs Ironwood Pharmaceuticals, Inc. (IRWD)
- Collegium Pharmaceutical, Inc. COLL 24.58 −2.31%
- Ironwood Pharmaceuticals, Inc. IRWD 4.39 +8.93%
Collegium Pharmaceutical, Inc. and Ironwood Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $819.1M against $665.9M — 1.2× the size. Ironwood Pharmaceuticals, Inc. trades at the lower P/E: 4.3× against 20.5×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 18.1% against 7.68%. Ironwood Pharmaceuticals, Inc. has the higher net margin (37.4% vs 4.68%) and the lower return on invested capital (0.00% vs 5.63%). Across the 20 metrics below, Ironwood Pharmaceuticals, Inc. leads on 12 and Collegium Pharmaceutical, Inc. on 8.
Valuation
Profitability
| Metric | COLL | IRWD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 59.05% | 100.00% | 53.51% |
| Operating margin | 15.22% | 62.91% | 0.00% |
| Net margin | 4.68% | 37.38% | (2.45%) |
| Free cash flow margin | 41.25% | 51.31% | 0.00% |
| Return on equity | 13.36% | (82.81%) | (0.80%) |
| Return on assets | 2.06% | 43.58% | (1.67%) |
| Return on invested capital | 5.63% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack